Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This trial is for people with non small cell lung cancer (NSCLC) who:
can’t have surgery to remove the lung cancer, or have chosen not to have an operation
are going to have stereotactic ablative radiotherapy (SABR) instead of surgery for lung cancer
It is for people who have an early stage (stage 1 or stage 2) NSCLC.
Recruitment start: 17 May 2019
Recruitment end: 5 April 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kevin Franks
Astra Zeneca
Last reviewed: 12 October 2024
CRUK internal database number: 16043